FealtySign in

Edwards Lifesciences Corp

(EW)

CIK 1099800 · SEC filings only

Not yet gradedBuyback record
harness minimum not met
company entity
0 resolved promises

Not enough resolved promises to grade

0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

buyback history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (1)

Open · buyback authorization

now totals approximately $2.1 billion

resolves in ~411 days$2.1000receipt →
0 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
B+Guidance record
grade
company entity
31 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (70)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. revenue guidance fy · Apr 23, 2026
    Raising FY 2026 constant currency 2 sales growth guidance to 9% to 11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance q · Apr 23, 2026
    For the second quarter of 2026, the company projects total sales to be between $1.66 and $1.74 billion and adjusted EPS of $0.70 to $0.76
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Apr 23, 2026
    Raising FY 2026 adjusted 2 EPS guidance midpoint; new range of $2.95 to $3.05
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance q · Oct 30, 2025
    adjusted EPS of $0.58 to $0.64
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Oct 30, 2025
    now expects adjusted EPS to be within the range of $2.56 to $2.62
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Jul 24, 2025
    The company now expects full-year adjusted EPS to be at the high end of its original range of $2.40 to $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance q · Jul 24, 2025
    adjusted EPS of $0.54 to $0.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Apr 23, 2025
    maintains its full-year operating margin guidance of 27% to 28% and EPS guidance of $2.40 to $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance q · Apr 23, 2025
    adjusted EPS of $0.59 to $0.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. revenue guidance fy · Feb 11, 2025
    Reiterating 2025 constant currency sales growth of 8% - 10%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance q · Feb 11, 2025
    adjusted EPS of $0.58 to $0.64
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Feb 11, 2025
    adjusted EPS of $2.40 - $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance q · Oct 24, 2024
    Q4 EPS of $0.53 to $0.57
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Apr 25, 2024
    The company is maintaining its full-year 2024 adjusted earnings per share guidance of $2.70 to $2.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance q · Apr 25, 2024
    adjusted EPS of $0.67 to $0.71
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance q · Feb 6, 2024
    adjusted EPS of $0.62 to $0.66
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance fy · Feb 6, 2024
    the company continues to expect full year 2024 adjusted earnings per share of $2.70 to $2.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. revenue guidance fy · Feb 6, 2024
    Full year 2024 sales are expected to grow 8 to 10 percent
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Oct 25, 2023
    the company continues to expect full year 2023 adjusted earnings per share of $2.50 to $2.60.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. revenue guidance fy · Oct 25, 2023
    The company continues to expect full-year total company and TAVR sales growth to be in the 10 to 13 percent range on a constant currency basis.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance q · Oct 25, 2023
    diluted earnings per share of $0.60 and $0.66.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Jul 26, 2023
    the company is lifting its full year 2023 adjusted earnings per share guidance to $2.50 to $2.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. revenue guidance fy · Jul 26, 2023
    The company now expects full-year total company and TAVR sales growth to be in the 10 to 13 percent range on a constant currency basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance q · Jul 26, 2023
    adjusted EPS of $0.55 to $0.61
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance q · Apr 26, 2023
    adjusted EPS of $0.62 to $0.68
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance fy · Apr 26, 2023
    the company is lifting its full year 2023 adjusted earnings per share guidance to $2.48 to $2.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. revenue guidance fy · Jan 31, 2023
    we expect 9 to 12 percent sales growth in 2023
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance q · Jan 31, 2023
    adjusted EPS of $0.58 to $0.64
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · Jan 31, 2023
    the company continues to expect full year 2023 adjusted earnings per share of $2.45 to $2.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance fy · Oct 27, 2022
    Edwards now expects full year adjusted EPS of $2.40 to $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance q · Oct 27, 2022
    The company expects reported sales and adjusted EPS to be similar to the third quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance q · Jul 28, 2022
    adjusted EPS of $0.58 to $0.66
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance fy · Jul 28, 2022
    The company now expects full year adjusted EPS guidance at the bottom end of its original guidance range of $2.50 to $2.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. revenue guidance fy · Apr 26, 2022
    Full year 2022 sales are expected to grow at a low double-digit underlying rate to $5.5 to $6.0 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance q · Apr 26, 2022
    adjusted EPS of $0.61 to $0.69
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance fy · Apr 26, 2022
    the company continues to expect full year 2022 adjusted earnings per share of $2.50 to $2.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance q · Jan 26, 2022
    adjusted EPS of $0.54 to $0.62
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Jan 26, 2022
    the company continues to expect full year 2022 adjusted earnings per share of $2.50 to $2.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance q · Oct 27, 2021
    adjusted EPS of $0.53 to $0.59
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Oct 27, 2021
    adjusted earnings per share guidance at the high end of $2.07 to $2.27
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. eps guidance q · Jul 29, 2021
    adjusted EPS of $0.50 to $0.56
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  42. eps guidance fy · Jul 29, 2021
    The company is raising full year 2021 adjusted earnings per share guidance to the high end of the previous $2.07 to $2.27 range
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance fy · Apr 20, 2021
    The company is raising full year 2021 adjusted earnings per share to $2.07 to $2.27 from $2.00 to $2.20.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  44. eps guidance q · Apr 20, 2021
    adjusted EPS of $0.54 to $0.60.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  45. eps guidance fy · Jan 27, 2021
    the company continues to expect full year 2021 adjusted earnings per share of $2.00 to $2.20.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  46. eps guidance q · Jan 27, 2021
    adjusted EPS of $0.43 to $0.50.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  47. eps guidance fy · Oct 22, 2020
    The company is raising the bottom end of full-year 2020 adjusted earnings per share guidance to $1.85 to $1.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  48. revenue guidance q · Oct 22, 2020
    the company anticipates year-over-year underlying sales growth similar to the third quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  49. eps guidance fy · Jul 23, 2020
    The company now expects full-year 2020 adjusted earnings per share of $1.75 to $1.95 on a post-split basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  50. eps guidance fy · Apr 23, 2020
    the company now expects full year 2020 adjusted earnings per share of $4.75 to $5.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  51. eps guidance fy · Oct 23, 2019
    the company raised its full year 2019 adjusted earnings per share guidance to $5.50 to $5.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  52. eps guidance q · Apr 23, 2019
    adjusted EPS of $1.27 to $1.37
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  53. eps guidance fy · Apr 23, 2019
    the company raised its full year 2019 adjusted earnings per share guidance to $5.10 to $5.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  54. eps guidance q · Jan 31, 2019
    adjusted EPS of $1.15 to $1.25.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  55. eps guidance fy · Jan 31, 2019
    the company continues to expect full year 2019 adjusted earnings per share to be between $5.05 and $5.30.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  56. eps guidance q · Jul 26, 2018
    adjusted EPS of $0.93 to $1.03
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  57. eps guidance fy · Jul 26, 2018
    the company is raising its estimate for 2018 adjusted earnings per share to be between $4.60 and $4.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  58. eps guidance fy · Feb 1, 2018
    the company now expects its estimate for 2018 adjusted earnings per share to be between $4.43 and $4.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  59. eps guidance q · Feb 1, 2018
    adjusted EPS of $1.04 to $1.14
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  60. revenue guidance q · Jul 26, 2017
    the company projects underlying sales, adjusting for the impact of Germany stocking sales consumption, to be between $810 and $850 million
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  61. eps guidance fy · Jul 26, 2017
    raising its estimate for 2017 a djusted earnings per share to $3.65 to $3.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  62. eps guidance q · Jul 26, 2017
    adjusted earnings per share of $0.80 to $0.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  63. eps guidance fy · Feb 1, 2017
    adjusted earnings per share to be between $3.30 and $3.45
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  64. eps guidance q · Feb 1, 2017
    adjusted earnings per share to be between $0.79 and $0.89
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  65. eps guidance q · Oct 25, 2016
    adjusted earnings per share to be between $0.67 and $0.77
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  66. eps guidance fy · Oct 25, 2016
    the company now expects adjusted earnings per share to be between $2.82 and $2.92
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  67. eps guidance fy · Apr 26, 2016
    the company now expects adjusted earnings per share to be between $2.67 and $2.77
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  68. eps guidance q · Apr 26, 2016
    adjusted earnings per share to be between $0.67 and $0.73
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  69. eps guidance q · Oct 26, 2015
    diluted earnings per share, excluding special items, to be between $1.11 and $1.21
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  70. eps guidance fy · Oct 26, 2015
    The company is increasing its guidance for full year 2015 diluted earnings per share, excluding special items, to a range of $4.43 to $4.53
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (10) · 19 superseded

Open · revenue guidance fy

The company continues to expect full year 2015 total sales to be between $2.3 billion to $2.5 billion.

unresolved — no outcome on filereceipt →
Open · revenue guidance q

For the fourth quarter of 2015, at current foreign exchange rates, the company projects total sales to be between $620 million and $660 million

unresolved — no outcome on filereceipt →
Open · revenue guidance q

the company projects sales to be between $700 and $740 million

unresolved — no outcome on filereceipt →
Open · revenue guidance q

the company projects sales to be between $750 and $790 million

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

the company continues to expect sales to be at the high end of its previous $2.7 to $3.0 billion range

unresolved — no outcome on filereceipt →
Open · revenue guidance q

the company projects sales to be between $760 and $800 million

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

the company's full year sales estimate is now at the high end of its previous $3.2 to $3.4 billion guidance

unresolved — no outcome on filereceipt →
Open · revenue guidance q

the company projects total sales to be between $900 and $950 million

unresolved — no outcome on filereceipt →
Open · revenue guidance q

For the fourth quarter of 2022, Edwards projects year-over-year and sequential sales growth in constant currency

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Edwards now expects total company sales of $6.5 to $6.9 billion

resolves in ~198 daysreceipt →
Superseded · revenue guidance fy

the company now expects full year 2023 sales to be at the high end of its $5.6 to $6.0 billion range

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2023 sales are expected to grow 9 to 12 percent to $5.6 to $6.0 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Increasing Edwards sales growth guidance to 9-10%

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Overall, 2019 sales guidance for total Edwards remains unchanged.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

sales of $5.9 billion to $6.1 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

the company continues to expect sales to be between $3.0 and $3.4 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2024 sales are expected to grow 8 to 10 percent to $6.3 to $6.6 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Edwards increased its sales estimate to be at the higher end of its $3.5 to $3.9 billion guidance

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Overall, the company now expects full year 2021 sales of $5.2 to $5.4 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Overall, full year 2021 sales guidance for Edwards remains at $4.9 to $5.3 billion.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Edwards now expects total company sales of $5.7 to $6.1 billion in 2025

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Overall, full year 2021 sales guidance for Edwards remains $4.9 to $5.3 billion.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Overall, 2019 sales guidance for Edwards of $3.9 to $4.3 billion remains unchanged.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2023 sales are expected to grow 10 to 12 percent

revised by a later guidancereceipt →
Superseded · revenue guidance fy

the company now expects full year 2022 sales of $5.35 to $5.55 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For the full year 2016, the company now expects sales to be between $2.7 and $3.0 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Overall, 2020 sales guidance for Edwards is now expected to be $4.0 to $4.5 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

the company now expects full-year 2024 sales growth to be at the high end of the prior guidance of 8 to 10% and $6.3 to $6.6 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2022 sales are expected to grow at a low double-digit rate to $5.5 to $6.0 billion.

revised by a later guidancereceipt →

Credibility timeline

KEPT · Oct 27, 2023BEAT · Feb 12, 2024KEPT · Feb 12, 2024KEPT · Apr 29, 2024MISSED · Jul 31, 2024MISSED · Feb 28, 2025KEPT · Feb 28, 2025KEPT · May 6, 2025BEAT · Aug 6, 2025BEAT · Nov 5, 2025KEPT · Feb 25, 2026BEAT · Feb 25, 2026
20232026
Timeline as a list
  • Oct 27, 2023KEPTFor the third quarter of 2023, the company projects total sales to be between $1.44 and $1.52 billion
  • Feb 12, 2024BEATFor the fourth quarter of 2023, the company projects total sales to be between $1.45 and $1.53 billion
  • Feb 12, 2024KEPTthe company now expects full year 2023 sales to be in the $5.9 to $6.1 billion range
  • Apr 29, 2024KEPTFor the first quarter of 2024, the company projects total sales to be between $1.53 and $1.61 billion
  • Jul 31, 2024MISSEDFor the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion
  • Feb 28, 2025MISSEDEdwards' full year sales growth guidance of 8 to 10% remains unchanged
  • Feb 28, 2025KEPTEdwards expects fourth quarter sales of $1.33 to $1.39 billion
  • May 6, 2025KEPTthe company projects total sales to be between $1.35 and $1.43 billion
  • Aug 6, 2025BEATFor the second quarter of 2025, the company projects total sales to be between $1.45 and $1.53 billion
  • Nov 5, 2025BEATthe company projects total sales to be between $1.46 and $1.54 billion
  • Feb 25, 2026KEPTprojects total sales to be between $1.51 and $1.59 billion
  • Feb 25, 2026BEATIncreasing sales growth guidance to high end of 9-10%
31 resolved guidance promises · 70dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →